tirzepatide for short term weight loss Semaglutide vs. Tirzepatide Long-Term Weight Loss and

Tirzepatide targets GLP-1 and GIP, enhancing appetite control and weight loss

Tirzepatide , a dual GLP-1/GIP agonist, has shown superior weight loss results in head-to-head comparisons

Research suggests that semaglutide, on insulin signaling, might disrupt the regulation of the HPA axis, neurotrophic factors, and neurotransmitters involved in depression and other mental health conditions

Why Starting Low is Critical Starting with a low dose is essential because semaglutide affects the digestive system and appetite-regulating hormones

PlexusDx can coordinate transition timing based on your treatment history and genetic profile to optimize appetite control throughout the switch